PortfoliosLab logo
GHC vs. APYX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between GHC and APYX is -0.20. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.


Performance

GHC vs. APYX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Graham Holdings Company (GHC) and Apyx Medical Corporation (APYX). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Daily Std Dev

GHC:

13.00%

APYX:

177.87%

Max Drawdown

GHC:

-0.42%

APYX:

-7.76%

Current Drawdown

GHC:

-0.42%

APYX:

-7.20%

Fundamentals

Market Cap

GHC:

$4.23B

APYX:

$43.84M

EPS

GHC:

$141.12

APYX:

-$0.66

PS Ratio

GHC:

0.88

APYX:

0.93

PB Ratio

GHC:

0.99

APYX:

3.09

Total Revenue (TTM)

GHC:

$4.80B

APYX:

$37.86M

Gross Profit (TTM)

GHC:

$1.42B

APYX:

$18.73M

EBITDA (TTM)

GHC:

$1.24B

APYX:

-$11.36M

Returns By Period


GHC

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

APYX

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

GHC vs. APYX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GHC
The Risk-Adjusted Performance Rank of GHC is 8484
Overall Rank
The Sharpe Ratio Rank of GHC is 8282
Sharpe Ratio Rank
The Sortino Ratio Rank of GHC is 8080
Sortino Ratio Rank
The Omega Ratio Rank of GHC is 7676
Omega Ratio Rank
The Calmar Ratio Rank of GHC is 9494
Calmar Ratio Rank
The Martin Ratio Rank of GHC is 8787
Martin Ratio Rank

APYX
The Risk-Adjusted Performance Rank of APYX is 4040
Overall Rank
The Sharpe Ratio Rank of APYX is 3333
Sharpe Ratio Rank
The Sortino Ratio Rank of APYX is 4747
Sortino Ratio Rank
The Omega Ratio Rank of APYX is 4545
Omega Ratio Rank
The Calmar Ratio Rank of APYX is 4040
Calmar Ratio Rank
The Martin Ratio Rank of APYX is 3737
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

GHC vs. APYX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Graham Holdings Company (GHC) and Apyx Medical Corporation (APYX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Dividends

GHC vs. APYX - Dividend Comparison

GHC's dividend yield for the trailing twelve months is around 0.73%, while APYX has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
GHC
Graham Holdings Company
0.73%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
APYX
Apyx Medical Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

GHC vs. APYX - Drawdown Comparison

The maximum GHC drawdown since its inception was -0.42%, smaller than the maximum APYX drawdown of -7.76%. Use the drawdown chart below to compare losses from any high point for GHC and APYX. For additional features, visit the drawdowns tool.


Loading data...

Volatility

GHC vs. APYX - Volatility Comparison


Loading data...

Financials

GHC vs. APYX - Financials Comparison

This section allows you to compare key financial metrics between Graham Holdings Company and Apyx Medical Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B1.20B20212022202320242025
1.17B
14.22M
(GHC) Total Revenue
(APYX) Total Revenue
Values in USD except per share items

GHC vs. APYX - Profitability Comparison

The chart below illustrates the profitability comparison between Graham Holdings Company and Apyx Medical Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%20212022202320242025
29.7%
63.0%
(GHC) Gross Margin
(APYX) Gross Margin
GHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Graham Holdings Company reported a gross profit of 346.56M and revenue of 1.17B. Therefore, the gross margin over that period was 29.7%.

APYX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Apyx Medical Corporation reported a gross profit of 8.96M and revenue of 14.22M. Therefore, the gross margin over that period was 63.0%.

GHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Graham Holdings Company reported an operating income of 47.47M and revenue of 1.17B, resulting in an operating margin of 4.1%.

APYX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Apyx Medical Corporation reported an operating income of -3.05M and revenue of 14.22M, resulting in an operating margin of -21.4%.

GHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Graham Holdings Company reported a net income of 23.89M and revenue of 1.17B, resulting in a net margin of 2.1%.

APYX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Apyx Medical Corporation reported a net income of -4.63M and revenue of 14.22M, resulting in a net margin of -32.5%.